ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 11 filers reported holding ZEALAND PHARMA A S in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $544,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 1,010,000 | $25,614,000 | 0.19% |
| AWM Investment Company, Inc. | 19,981 | $507,000 | 0.11% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,686,496 | $42,768,000 | 0.01% |
| STATE OF WISCONSIN INVESTMENT BOARD | 44,092 | $1,118,000 | 0.00% |
| ROYCE & ASSOCIATES LP | 10,000 | $254,000 | 0.00% |
| Winslow, Evans & Crocker, Inc. | 236 | $6,000 | 0.00% |
| JANE STREET GROUP, LLC | 11,942 | $304,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 8,537 | $216,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 39 | $1,000 | 0.00% |